Verrica制药 内部交易概览
最近18个月交易的高管股东 | 交易次数 | 净买入(股) |
---|---|---|
Perceptive Life Sciences Master Fund Ltd | 3 | 2,060,199 |
Gary Goldenberg | 2 | -37,552 |
Ted White | 2 | -84,376 |
Joe Bonaccorso | 2 | -71,108 |
Christopher G. Hayes | 2 | -67,488 |
Paul B Manning | 1 | 200,000 |
交易分段汇总 | 买入数量 | 卖出数量 | 净买入(股) |
---|---|---|---|
最近1个月 | 0 | 0 | 0 |
最近3个月 | 0 | 0 | 0 |
最近6个月 | 2,060,199 | 137,181 | 1,923,018 |
最近12个月 | 2,260,199 | 288,608 | 1,971,591 |
Verrica制药 内部交易
Verrica制药 最新内部交易
Perceptive Life Sciences Master Fund Ltd | 10% Owner | 2023-12-29 | 买入 | 321,616 | 7,099,182 |
$7.17
|
+1.95%
|
Perceptive Life Sciences Master Fund Ltd | 10% Owner | 2023-12-26 | 买入 | 504,652 | 6,777,566 |
$6.45
|
+13.33%
|
Perceptive Life Sciences Master Fund Ltd | 10% Owner | 2023-12-19 | 买入 | 1,233,931 | 6,272,914 |
$5.63
|
+29.84%
|
Joe Bonaccorso | Chief Commercial Officer | 2023-11-15 | 卖出 | 32,846 | 92,392 |
$2.94
|
+148.64%
|
Terry Kohler | CFO | 2023-11-15 | 卖出 | 28,084 | 34,416 |
$2.94
|
+148.64%
|
Ted White | President & CEO | 2023-11-15 | 卖出 | 33,699 | 170,090 |
$2.94
|
+148.64%
|
Christopher G. Hayes | Chief Legal Officer | 2023-11-15 | 卖出 | 33,699 | 123,226 |
$2.94
|
+148.64%
|
Gary Goldenberg | Chief Medical Officer | 2023-11-15 | 卖出 | 8,853 | 86,257 |
$2.94
|
+148.64%
|
Gary Goldenberg | Chief Medical Officer | 2023-07-24 | 卖出 | 28,699 | 70,110 |
$4.83
|
+51.35%
|
Ted White | President & CEO | 2023-07-24 | 卖出 | 50,677 | 128,789 |
$4.83
|
+51.35%
|